Lidocaine Hydrochloride

CHEMBL1200409 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
270.8 g/mol
LogP
Phase
4

The hydrochloride salt form of lidocaine, the most commonly used preparation for local anesthesia and intravenous antiarrhythmic therapy. It is used in everything from dental procedures to treating life-threatening arrhythmias.

Peso molecular

270,8000 g/mol

TPSA

32,30 Ų

Áreas terapéuticas

Mecanismo de acción

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl.O

InChI

InChI=1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2

Molecular Formula

C14H23ClN2O

HBD / HBA

2 / 2

Enlaces Rotables

5

Átomos Pesados

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The hydrochloride salt form of lidocaine, the most commonly used preparation for local anesthesia and intravenous antiarrhythmic therapy. It is used in everything from dental procedures to treating life-threatening arrhythmias.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Lidocaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200409. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6314. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.